The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Antifibrinolytic agents in current anaesthetic practice
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006–2008
(2011) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2010.02847.x · Cited by 2,994
Hemostasis and Thrombosis: Basic Principles and Clinical Practice.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-504_7 · Cited by 1,854
Maternal mortality: who, when, where, and why
Ronsmans, C., & Graham, W. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69380-x · Cited by 1,801
Murphy, G. J., Reeves, B. C., Rogers, C. A., Rizvi, S. I. A., Culliford, L., & Angelini, G. D. (2007) · Circulation · doi:10.1161/circulationaha.107.698977 · Cited by 1,371
Early Coagulopathy Predicts Mortality in Trauma
MacLeod, J. B. A., Lynn, M., McKenney, M. G., Cohn, S. M., & Murtha, M. (2003) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/01.ta.0000075338.21177.ef · Cited by 1,224
A Comparison of Aprotinin and Lysine Analogues in High-Risk Cardiac Surgery
Fergusson, D. A., Hébert, P. C., Mazer, C. D., Fremes, S., MacAdams, C., Murkin, J. M., Teoh, K., Duke, P. C., Arellano, R., Blajchman, M. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802395 · Cited by 1,152
The Risk Associated with Aprotinin in Cardiac Surgery
Mangano, D. T., Tudor, I. C., & Dietzel, C. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051379 · Cited by 1,099
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
Henry, D. A., Carless, P. A., Moxey, A. J., O’Connell, D. L., Stokes, B., Fergusson, D. A., & Ker, K. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001886.pub4 · Cited by 1,065
Research works printed but not linked: 51
- Cardone, 2009, Perioperative blood conservation, Eur J Anaesthesiol, 26, 722, 10.1097/EJA.0b013e32832c5280 · doi:10.1097/eja.0b013e32832c5280
- Dietrich, 1996, Reducing thrombin formation during cardiopulmonary bypass: is there a benefit of the additional anticoagulant action of aprotinin?, J Cardiovasc Pharmacol, 27, S50, 10.1097/00005344-199600001-00011 · doi:10.1097/00005344-199600001-00011
- Westaby, 1993, Aprotinin in perspective, Ann Thorac Surg, 55, 1033, 10.1016/0003-4975(93)90149-C · doi:10.1016/0003-4975(93)90149-c
- Greilich, 2003, Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of epsilon-aminocaproic acid and aprotinin, J Thorac Cardiovasc Surg, 126, 1498, 10.1016/S0022-5223(03)00946-2 · doi:10.1016/s0022-5223(03)00946-2
- Dorman, 2008, Differential effects of epsilon-aminocaproic acid and aprotinin on matrix metalloproteinase release in patients following cardiopulmonary bypass, J Cardiovasc Pharmacol, 51, 418, 10.1097/FJC.0b013e318168400a · doi:10.1097/fjc.0b013e318168400a
- Greilich, 2001, Aprotinin but not epsilon-aminocaproic acid decreases interleukin-10 after cardiac surgery with extracorporeal circulation: randomized, double-blind, placebo-controlled study in patients receiving aprotinin and epsilon-aminocaproic acid, Circulation, 104, I265, 10.1161/hc37t1.094781 · doi:10.1161/hc37t1.094781
- Brown, 2009, Anti-inflammatory effect of aprotinin: a meta-analysis, J Extra Corpor Technol, 41, 79, 10.1051/ject/200941079 · doi:10.1051/ject/200941079
- Dietrich, 2007, Aprotinin and anaphylaxis: analysis of 12,403 exposures to aprotinin in cardiac surgery, Ann Thorac Surg, 84, 1144, 10.1016/j.athoracsur.2007.05.015 · doi:10.1016/j.athoracsur.2007.05.015
- Horrow, 1991, Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery, Circulation, 84, 2063, 10.1161/01.CIR.84.5.2063 · doi:10.1161/01.cir.84.5.2063
- Shore-Lesserson, 1996, Tranexamic acid reduces transfusions and mediastinal drainage in repeat cardiac surgery, Anesth Analg, 83, 18, 10.1213/00000539-199607000-00005 · doi:10.1213/00000539-199607000-00005
- Karski, 1995, Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid. Double-blind, randomized clinical trial, J Thorac Cardiovasc Surg, 110, 835, 10.1016/S0022-5223(95)70118-4 · doi:10.1016/s0022-5223(95)70118-4
- Butterworth, 1999, Pharmacokinetics of epsilon-aminocaproic acid in patients undergoing aortocoronary bypass surgery, Anesthesiology, 90, 1624, 10.1097/00000542-199906000-00019 · doi:10.1097/00000542-199906000-00019
- Mohseni, 2009, Polymyoclonus seizure resulting from accidental injection of tranexamic acid in spinal anesthesia, Anesth Analg, 108, 1984, 10.1213/ane.0b013e3181a04d69 · doi:10.1213/ane.0b013e3181a04d69
- Garcha, 2007, Death after an inadvertent intrathecal injection of tranexamic acid, Anesth Analg, 104, 241, 10.1213/01.ane.0000250436.17786.72 · doi:10.1213/01.ane.0000250436.17786.72
- Yeh, 2003, Convulsions and refractory ventricular fibrillation after intrathecal injection of a massive dose of tranexamic acid, Anesthesiology, 98, 270, 10.1097/00000542-200301000-00042 · doi:10.1097/00000542-200301000-00042
- Martin, 2011, Seizures after open heart surgery: comparison of epsilon-aminocaproic acid and tranexamic acid, J Cardiothorac Anesth, 25, 20, 10.1053/j.jvca.2010.10.007 · doi:10.1053/j.jvca.2010.10.007
- Keyl, 2011, High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement, Eur J Cardiothorac Surg, 39, e114, 10.1016/j.ejcts.2010.12.030 · doi:10.1016/j.ejcts.2010.12.030
- Umlas, 1976, Fibrinolysis and disseminated intravascular coagulation in open heart surgery, Transfusion, 16, 460, 10.1046/j.1537-2995.1976.16577039303.x · doi:10.1046/j.1537-2995.1976.16577039303.x
- Tanaka, 1989, Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery, J Cardiothorac Anesth, 3, 181, 10.1016/S0888-6296(89)92642-2 · doi:10.1016/s0888-6296(89)92642-2
- Ngaage, 2010, Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis of randomised and large matched observational studies, Eur J Cardiothorac Surg, 37, 1375, 10.1016/j.ejcts.2009.11.055 · doi:10.1016/j.ejcts.2009.11.055
- Karkouti, 2010, The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery, Anesth Analg, 110, 21, 10.1213/ANE.0b013e3181c0ea6d · doi:10.1213/ane.0b013e3181c0ea6d
- Sander, 2010, Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis, Crit Care, 14, R148, 10.1186/cc9216 · doi:10.1186/cc9216
- Pasquali, 2012, Comparative analysis of antifibrinolytic medications in pediatric heart surgery, J Thorac Cardiovasc Surg, 143, 550, 10.1016/j.jtcvs.2011.06.048 · doi:10.1016/j.jtcvs.2011.06.048
- Shimizu, 2011, Effect of tranexamic acid on blood loss in pediatric cardiac surgery: a randomized trial, J Anesth, 25, 823, 10.1007/s00540-011-1235-z · doi:10.1007/s00540-011-1235-z
- Martin, 2011, Tranexamic acid versus varepsilon-aminocaproic acid: efficacy and safety in paediatric cardiac surgery, Eur J Cardiothorac Surg, 39, 892, 10.1016/j.ejcts.2010.09.041 · doi:10.1016/j.ejcts.2010.09.041
- Martin, 2011, Switch from aprotinin to epsilon-aminocaproic acid: impact on blood loss, transfusion, and clinical outcome in neonates undergoing cardiac surgery, Br J Anaesth, 107, 934, 10.1093/bja/aer267 · doi:10.1093/bja/aer267
- Martin, 2013, Replacement of aprotinin by {varepsilon}-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome, Br J Anaesth, 110, 615, 10.1093/bja/aes430 · doi:10.1093/bja/aes430
- Kon, 2006, Off-pump coronary artery bypass leads to a regional hypercoagulable state not detectable using systemic markers, Innovations (Phila), 1, 232, 10.1097/01.imi.0000242160.21278.b7 · doi:10.1097/01.imi.0000242160.21278.b7
- Raja, 2011, Hypercoagulable state after off-pump coronary artery bypass grafting: evidence, mechanisms and implications, Expert Rev Cardiovasc Ther, 9, 599, 10.1586/erc.11.51 · doi:10.1586/erc.11.51
- Desai, 2009, A randomized clinical trial investigating the relationship between aprotinin and hypercoagulability in off-pump coronary surgery, Anesth Analg, 109, 1387, 10.1213/ANE.0b013e3181b81068 · doi:10.1213/ane.0b013e3181b81068
- Weber, 2011, Tranexamic acid partially improves platelet function in patients treated with dual antiplatelet therapy, Eur J Anaesthesiol, 28, 57, 10.1097/EJA.0b013e32834050ab · doi:10.1097/eja.0b013e32834050ab
- Tauber, 2011, Prevalence and impact of abnormal ROTEM(R) assays in severe blunt trauma: results of the ‘Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study’, Br J Anaesth, 107, 378, 10.1093/bja/aer158 · doi:10.1093/bja/aer158
- Wong, 2008, Tranexamic acid reduces perioperative blood loss in adult patients having spinal fusion surgery, Anesth Analg, 107, 1479, 10.1213/ane.0b013e3181831e44 · doi:10.1213/ane.0b013e3181831e44
- Dhawale, 2012, Are antifibrinolytics helpful in decreasing blood loss and transfusions during spinal fusion surgery in children with cerebral palsy scoliosis?, Spine, 37, E549, 10.1097/BRS.0b013e31823d009b · doi:10.1097/brs.0b013e31823d009b
- Verma, 2010, A prospective, randomized, double-blinded single-site control study comparing blood loss prevention of tranexamic acid (TXA) to epsilon aminocaproic acid (EACA) for corrective spinal surgery, BMC Surg, 10, 13, 10.1186/1471-2482-10-13 · doi:10.1186/1471-2482-10-13
- Roullet, 2010, Rotation thromboelastometry detects thrombocytopenia and hypofibrinogenaemia during orthotopic liver transplantation, Br J Anaesth, 104, 422, 10.1093/bja/aeq022 · doi:10.1093/bja/aeq022
- Porte, 2000, Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group, Lancet, 355, 1303, 10.1016/S0140-6736(00)02111-5 · doi:10.1016/s0140-6736(00)02111-5
- Dalmau, 2000, Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation, Anesth Analg, 91, 29
- Dalmau, 2004, The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study, Liver Transpl, 10, 279, 10.1002/lt.20075 · doi:10.1002/lt.20075
- Massicotte, 2011, Aprotinin versus tranexamic acid during liver transplantation: impact on blood product requirements and survival, Transplantation, 91, 1273, 10.1097/TP.0b013e31821ab9f8 · doi:10.1097/tp.0b013e31821ab9f8
- Ickx, 2006, Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation, Transfusion, 46, 595, 10.1111/j.1537-2995.2006.00770.x · doi:10.1111/j.1537-2995.2006.00770.x
- Warnaar, 2009, Aprotinin and the risk of thrombotic complications after liver transplantation: a retrospective analysis of 1492 patients, Liver Transpl, 15, 747, 10.1002/lt.21768 · doi:10.1002/lt.21768
- Trzebicki, 2010, The use of thromboelastometry in the assessment of hemostasis during orthotopic liver transplantation reduces the demand for blood products, Ann Transplant, 15, 19
- Gorlinger, 2006, Coagulation management during liver transplantation, Hamostaseologie, 26, S64, 10.1055/s-0037-1617084 · doi:10.1055/s-0037-1617084
- Gohel, 2007, Efficacy of tranexamic acid in decreasing blood loss during and after cesarean section: a randomised case controlled prospective study, J Obstet Gynaecol India, 57, 227
- Rosenorn, 1987, The risk of rebleeding from ruptured intracranial aneurysms, J Neurosurg, 67, 329, 10.3171/jns.1987.67.3.0329 · doi:10.3171/jns.1987.67.3.0329
- Starke, 2011, Rebleeding after aneurysmal subarachnoid hemorrhage, Neurocritical Care, 15, 241, 10.1007/s12028-011-9581-0 · doi:10.1007/s12028-011-9581-0
- Roos, 2000, Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR Study Group, Neurology, 54, 77, 10.1212/WNL.54.1.77 · DOI
- Hillman, 2002, Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study, J Neurosurg, 97, 771, 10.3171/jns.2002.97.4.0771 · DOI
- Starke, 2008, Impact of a protocol for acute antifibrinolytic therapy on aneurysm rebleeding after subarachnoid hemorrhage, Stroke, 39, 2617, 10.1161/STROKEAHA.107.506097 · doi:10.1161/strokeaha.107.506097
- Harrigan, 2010, Short-term antifibrinolytic therapy before early aneurysm treatment in subarachnoid hemorrhage: effects on rehemorrhage, cerebral ischemia, and hydrocephalus, Neurosurgery, 67, 935, 10.1227/NEU.0b013e3181ebaa36 · doi:10.1227/neu.0b013e3181ebaa36
Cited by
Tranexamic acid: a clinical review
Ng, W. C. K., Jerath, A., & Wasowicz, M. (2015) · Anestezjologia Intensywna Terapia · doi:10.5603/ait.a2015.0011 · Cited by 325
Dupanovic, M. (2015) · Encyclopedia of Trauma Care · doi:10.1007/978-3-642-29613-0_456
Metadata
- Authors
- Ortmann, E., Besser, M. W., & Klein, A. A.
- Venue
- British Journal of Anaesthesia
- Publisher
- Elsevier BV
- Published
- 2013-10
- Volume
- 111
- Issue
- 4
- Pages
- 549-563
- ISSN
- 0007-0912 (ISSN-L)
- OpenAlex
- W2132175922
- Cited by
- 262
- References
- 62
- FWCI
- 14.68
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 1525 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antifibrinolytic agents in current anaesthetic practice. https://app.cochat.ai/papers/10.1093/bja/aet154
- The paper
- Ortmann, E., Besser, M. W., & Klein, A. A. (2013). Antifibrinolytic agents in current anaesthetic practice. British Journal of Anaesthesia. https://doi.org/10.1093/bja/aet154
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.